Michael Meyers is managing director and head of investment banking at T.R. Winston & Company, a merchant, corporate and investment banking firm. He has over 23 years of experience in investment banking, venture capital and asset management.
Prior to joining T.R. Winston, Michael Meyers was the CEO and chief investment officer of Arcoda Capital Management LP, a healthcare focused fund. Prior to founding Arcoda in 2007, Mr. Meyers was a partner and portfolio manager with GoldenTree Asset Management LP, a $17 billion multi-strategy asset management firm. Between 2002 and 2006, Mr. Meyers was a founding managing partner, portfolio manager and sector head of healthcare of Trivium Capital Management LLC. Between 2000 and 2003, Mr. Meyers was a managing director, partner and member of the board of directors of Global Biomedical Partners AG, a life sciences venture capital and private equity firm located in New York and Zurich, Switzerland that was acquired by HBM Bioventures in 2003.
Prior to 2003, Mr. Meyers was director and relationship manager, biotechnology and pharmaceutical investment banking with Merrill Lynch & Co. He was also a vice president of health care investment banking with Cowen & Company. Mr. Meyers began his career as a biotechnology and medical device research associate at Hambrecht & Quist in New York.
He is the father of Rachel, a current BA freshman at the School of Dramatic Arts. He’s on the Medical Clowning Advisory Board and is entrenched in the medical and philanthropic communities. He has also served on the board of directors of five healthcare companies.
Mr. Meyers holds an MPH in Health Policy and Management from Columbia University and an AB in Biology from Brandeis University.